Jason Aryeh

Jason M.
Aryeh is the founder of JALAA Equities LP, founded in 1997, where the title held is Managing General Partner.
Mr. Aryeh was the founder of Rio Grande Renewables LLC, founded in 2009, where the title held was Chairman.
Current jobs include Independent Director at Ligand Pharmaceuticals, Inc. since 2006; Director at Orchestra BioMed, Inc. since 2018; Director at Cytovia Therapeutics, Inc. since 2021; Independent Director at Anebulo Pharmaceuticals, Inc. since 2021; Independent Non-Executive Director at Orchestra Biomed Holdings, Inc. since 2023; Director at Cytovia, Inc. (Massachusetts); Independent Director at Lifecore Biomedical, Inc. since 2024; and Member at Omicron Delta Epsilon.
Former jobs include Vice Chairman at Immunomedics, Inc. in 2017; Chairman at Novelion Therapeutics, Inc. from 2012 to 2018; Director at QLT, Inc. in 2012; Independent Director at Nabi Biopharmaceuticals from 2011 to 2012; Director at CorMatrix Cardiovascular, Inc. from 2010 to 2017; Independent Director at Myrexis, Inc. from 2011 to 2013; Director at Cystic Fibrosis Foundation Therapeutics, Inc. from 2011 to 2018; and Independent Director at Old API Wind-down Ltd. from 2016 to 2017.
Education includes undergraduate studies at Colgate University.